Detalhe da pesquisa
1.
Efficacy and Safety of Bepirovirsen in Chronic Hepatitis B Infection.
N Engl J Med
; 387(21): 1957-1968, 2022 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-36346079
2.
HBV DNA and HBsAg Levels at 24 Weeks Off-Treatment Predict Clinical Relapse and HBsAg Loss in HBeAg-Negative Patients Who Discontinued Antiviral Therapy.
Gastroenterology
; 166(1): 168-177.e8, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37769952
3.
Effects of empagliflozin on liver fat in patients with metabolic dysfunction-associated steatotic liver disease without diabetes mellitus: A randomized, double-blind, placebo-controlled trial.
Hepatology
; 2024 Mar 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-38536017
4.
Optimal glycaemic control and the reduced risk of colorectal adenoma and cancer in patients with diabetes: a population-based cohort study.
Gut
; 2024 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38569845
5.
Chronic Hepatitis B Finite Treatment: Similar and Different Concerns With New Drug Classes.
Clin Infect Dis
; 78(4): 983-990, 2024 Apr 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37633256
6.
ALT to qHBsAg ratio predicts long-term HBsAg seroclearance after entecavir cessation in Chinese patients with chronic hepatitis B.
J Hepatol
; 2024 Mar 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527527
7.
Limited Sustained Remission After Nucleos(t)ide Analog Withdrawal: Results From a Large, Global, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 2024 Apr 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-38483300
8.
SGLT2i reduces risk of developing HCC in patients with co-existing type 2 diabetes and hepatitis B infection: A territory-wide cohort study in Hong Kong.
Hepatology
; 78(5): 1569-1580, 2023 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37055020
9.
Glycemic burden and the risk of adverse hepatic outcomes in patients with chronic hepatitis B with type 2 diabetes.
Hepatology
; 77(2): 606-618, 2023 02 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36130882
10.
Steatosis, HBV-related HCC, cirrhosis, and HBsAg seroclearance: A systematic review and meta-analysis.
Hepatology
; 77(5): 1735-1745, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36111362
11.
Plasma interferon-gamma-inducible-protein 10 level as a predictive factor of spontaneous hepatitis B surface antigen seroclearance in chronic hepatitis B patients.
J Gastroenterol Hepatol
; 39(1): 202-209, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-37794699
12.
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study.
J Gastroenterol Hepatol
; 2024 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38480009
13.
Effect of Antiviral Treatment on Hepatitis B Virus Integration and Hepatocyte Clonal Expansion.
Clin Infect Dis
; 76(3): e801-e809, 2023 02 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35594553
14.
First-in-human randomized study of RNAi therapeutic RG6346 for chronic hepatitis B virus infection.
J Hepatol
; 79(5): 1139-1149, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37524230
15.
A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis.
J Hepatol
; 78(4): 684-692, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36513186
16.
Evaluation of RNAi therapeutics VIR-2218 and ALN-HBV for chronic hepatitis B: Results from randomized clinical trials.
J Hepatol
; 79(4): 924-932, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37290591
17.
Differential Relapse Patterns After Discontinuation of Entecavir vs Tenofovir Disoproxil Fumarate in Chronic Hepatitis B.
Clin Gastroenterol Hepatol
; 21(6): 1513-1522.e4, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-35863683
18.
Off-Therapy Response After Nucleos(t)ide Analogue Withdrawal in Patients With Chronic Hepatitis B: An International, Multicenter, Multiethnic Cohort (RETRACT-B Study).
Gastroenterology
; 162(3): 757-771.e4, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34762906
19.
Incidence of Hepatic Decompensation After Nucleos(t)ide Analog Withdrawal: Results From a Large, International, Multiethnic Cohort of Patients With Chronic Hepatitis B (RETRACT-B Study).
Am J Gastroenterol
; 118(9): 1601-1608, 2023 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36719174
20.
Safety, pharmacokinetics and antiviral activity of ABI-H2158, a hepatitis B virus core inhibitor: A randomized, placebo-controlled phase 1 study.
J Viral Hepat
; 30(3): 209-222, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36302125